RecruitingNCT04565119
Biomarkers in the Brain Oxygen Optimization in Severe Traumatic Brain Injury Trial
Biomarkers in the Brain Oxygen Optimization in Severe Traumatic Brain Injury Trial (BioBOOST)
Sponsor
University of Pennsylvania
Enrollment
300 participants
Start Date
Dec 20, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
BioBOOST is a multicenter, observational study of the effect of derangements in brain physiologic parameters on brain injury biomarker levels in patients with severe traumatic brain injury.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Enrolled in BOOST-3 (this is an ancillary study to the BOOST-3 trial)
- BOOST-3 participant is enrolled at a BioBOOST site
- Able to maintain initial blood sample within 24 hours of injury
- Provide proxy informed consent
Exclusion Criteria2
- Profoundly anemic (subjects who are profoundly anemic require blood transfusion)
- Age less than 18 years
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERNo intervention. This is an observational study.
There are no interventions being tested in the Bio-BOOST study.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04565119
Related Trials
Individual Cerebral Hemodynamic Oxygenation Relationships (ICHOR 1)
NCT061953451 location
Long Lasting Effect of Hyperbaric Oxygen Therapy on Cognitive Function in Traumatic Brain Injury Patients
NCT074301501 location
Stimulating After Recovery From Traumatic Brain Injury
NCT053278291 location
Cognitive Rehabilitation for Refugees With Traumatic Brain Injury and Cognitive Impairment
NCT068390791 location
Brain Development in Young Children Following Mild Traumatic Brain Injury - Pilot Study
NCT060241221 location